SciSparc Ltd. filed a Form F-3 registration statement with the SEC on November 9, 2026, covering the resale of up to 76,807,229 ordinary shares by a selling shareholder in connection with a convertible promissory note and accompanying warrant issued under a securities purchase agreement signed November 3, 2026.
Key Highlights
- Shares registered for resale: Up to 76,807,229 ordinary shares, no par value, consisting of 26,606,426 Note Shares and 50,200,803 Warrant Shares.
- Initial Promissory Note: Principal amount of $3.0 million, issued to the selling shareholder at a purchase price of $2.55 million (85% of principal) at the Initial Closing on November 3, 2026.
- Total facility: The securities purchase agreement allows for aggregate convertible promissory notes of up to $10 million in principal, for an aggregate purchase price of $8.5 million.
- Conversion pricing: The note converts at the lower of a fixed price of $0.5237 or 85% of the lowest daily VWAP over the prior 20 consecutive trading days, with a floor price of $0.11952 per share.
- Warrant exercise price: $0.5237 per Warrant Share; if exercised at this price, the warrant converts into 11,457,269 ordinary shares.
- Last reported share price: $0.4186 on November 6, 2026, as reported in the filing.
- No company proceeds from resale: SciSparc will not receive proceeds from the selling shareholder's resale of the registered shares, though it may receive cash proceeds if the warrant is exercised for cash.
SciSparc's $10 Million Convertible Note Facility and Resale Registration Details
According to the filing, SciSparc Ltd. (NASDAQ:SPRC) entered into a securities purchase agreement on November 3, 2026 with a single selling shareholder. Under that agreement, the company may issue convertible promissory notes in an aggregate principal amount of up to $10 million, with proceeds to SciSparc equal to 85% of the principal amount of each note purchased. At the Initial Closing, SciSparc issued a promissory note with a principal amount of $3.0 million for a purchase price of $2.55 million, together with an accompanying warrant.
The prospectus discloses that the Initial Promissory Note carries a fixed conversion price of $0.5237 per share, subject to a variable pricing mechanism under which conversion may occur at 85% of the lowest daily volume weighted average price during the 20 consecutive trading days immediately preceding the conversion date, with a floor conversion price of $0.11952. The filing notes that if converted at the fixed price, the Initial Promissory Note principal would result in 5,728,635 ordinary shares, while conversion at the floor price underlies the registration of 26,606,426 Note Shares. Similarly, the warrant is exercisable into 11,457,269 ordinary shares at the current exercise price of $0.5237, but the filing registers 50,200,803 Warrant Shares based on the floor price.
The filing states that beginning January 1, 2027, SciSparc may, at its sole discretion, request that the selling shareholder purchase additional promissory notes of up to $3.0 million each per quarter, subject to conditions in the securities purchase agreement, provided that total notes under the facility do not exceed $10 million in aggregate principal. Any shares underlying those additional notes and warrants would be registered separately. SciSparc's ordinary shares are listed on the Nasdaq Capital Market under the symbol "SPRC," according to the prospectus.
What Was Disclosed
SciSparc filed a preliminary Form F-3 registration statement on November 9, 2026, registering up to 76,807,229 ordinary shares for resale by a selling shareholder, arising from a $3.0 million convertible promissory note and warrant issued November 3, 2026, under a securities purchase agreement providing for up to $10 million in total notes.




Please wait processing your request...